We hypothesized that neurally adjusted ventilatory assist (NAVA) compared to conventional lung-protective mechanical ventilation (MV) decreases duration of MV and mortality in patients with acute respiratory failure (ARF).

We carried out a multicenter, randomized, controlled trial in patients with ARF from several etiologies. Intubated…[Weiterlesen]